Fulgent Genetics, Inc.

DB:7F0 Stock Report

Market Cap: €524.9m

Fulgent Genetics Management

Management criteria checks 2/4

Fulgent Genetics' CEO is Ming Hsieh, appointed in May 2016, has a tenure of 8.5 years. total yearly compensation is $5.31M, comprised of 18.8% salary and 81.2% bonuses, including company stock and options. directly owns 28.52% of the company’s shares, worth €149.72M. The average tenure of the management team and the board of directors is 4.7 years and 3.8 years respectively.

Key information

Ming Hsieh

Chief executive officer

US$5.3m

Total compensation

CEO salary percentage18.8%
CEO tenure8.5yrs
CEO ownership28.5%
Management average tenure4.7yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ming Hsieh's remuneration changed compared to Fulgent Genetics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$165m

Jun 30 2024n/an/a

-US$163m

Mar 31 2024n/an/a

-US$166m

Dec 31 2023US$5mUS$1m

-US$168m

Sep 30 2023n/an/a

-US$64m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$5mUS$948k

US$143m

Sep 30 2022n/an/a

US$272m

Jun 30 2022n/an/a

US$392m

Mar 31 2022n/an/a

US$461m

Dec 31 2021US$6mUS$664k

US$507m

Sep 30 2021n/an/a

US$569m

Jun 30 2021n/an/a

US$493m

Mar 31 2021n/an/a

US$417m

Dec 31 2020US$248kUS$240k

US$214m

Sep 30 2020n/an/a

US$48m

Jun 30 2020n/an/a

US$3m

Mar 31 2020n/an/a

-US$459k

Dec 31 2019US$240kUS$240k

-US$411k

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$240kUS$240k

-US$6m

Sep 30 2018n/an/a

-US$5m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$5m

Dec 31 2017US$240kUS$240k

-US$3m

Compensation vs Market: Ming's total compensation ($USD5.31M) is above average for companies of similar size in the German market ($USD1.03M).

Compensation vs Earnings: Ming's compensation has increased whilst the company is unprofitable.

CEO

Ming Hsieh (68 yo)

8.5yrs

Tenure

US$5,309,167

Compensation

Mr. Ming Hsieh has been an Independent Director of Fortinet, Inc. since April 2013. He is the Founder of Fulgent Genetics, Inc. and had been its President until May 2022 & serves as its Chief Executive Off...

Leadership Team

NamePositionTenureCompensationOwnership
Ming Hsieh
Chairman & CEO8.5yrsUS$5.31m28.52%
€ 149.7m
Jian Xie
COO & President6.6yrsUS$1.79m1.42%
€ 7.4m
Paul Kim
Chief Financial Officer8.8yrsUS$1.78m0.40%
€ 2.1m
Hanlin Gao
Chief Scientific Officer & Laboratory Director8.2yrsUS$1.49m2.8%
€ 14.7m
Natalie Prescott
General Counsel & Chief Privacy Officer2.5yrsno datano data
Doreen Ng
VP of Operations & Compliance and GM of Houston Office4.1yrsno datano data
Jakub Sram
Vice President of Business Development & Sales9.8yrsno datano data
Ellen Tsui
Vice President of Human Resources2.5yrsno datano data
Brandon Perthuis
Chief Commercial Officer4.7yrsno datano data
Lawrence Weiss
Chief Medical Officer3.5yrsno datano data
Ray Yin
President & Chief Scientific Officer of Fulgent Pharma2yrsno datano data

4.7yrs

Average Tenure

58yo

Average Age

Experienced Management: 7F0's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ming Hsieh
Chairman & CEO8.5yrsUS$5.31m28.52%
€ 149.7m
Regina Groves
Independent Non-Employee Director1.8yrsUS$625.60k0.0039%
€ 20.4k
Linda Marsh
Independent Director5.3yrsUS$270.50k0.061%
€ 320.2k
Michael Nohaile
Independent Non-Employee Director2.3yrsUS$268.50k0.0078%
€ 40.9k

3.8yrs

Average Tenure

67yo

Average Age

Experienced Board: 7F0's board of directors are considered experienced (3.8 years average tenure).